The side effects of silver sulfadiazine

Journal of Burn Care and Research

Volumn 30, Issue 3, 2009, Pages 464-470

  Fuller, Frederick W ^a  

^a SAINT BARNABAS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTICOAT; ALKALINE PHOSPHATASE; AMPHOTERICIN B; CEFIXIME; CERIUM; COTRIMOXAZOLE; CYCLOPHOSPHAMIDE; GENTAMICIN; MAFENIDE ACETATE; METHEMOGLOBIN; NITRATE; POVIDONE IODINE; PREDNISONE; PROPYLENE GLYCOL; SILVER; SILVER NITRATE; STEROID; SULFADIAZINE SILVER; TOPICAL ANTIINFECTIVE AGENT; UNCLASSIFIED DRUG;

ADVERSE DRUG REACTION; ALKALINE PHOSPHATASE BLOOD LEVEL; ANTIBIOTIC RESISTANCE; ARGYRIA; ARTICLE; AUTOPSY; BACTERIAL COLONIZATION; BACTERICIDAL ACTIVITY; BURN; BURN INFECTION; CANDIDA ALBICANS; CANDIDA TROPICALIS; CHEMICAL BURN; CHEMOSENSITIVITY; DEBRIDEMENT; DELAYED HYPERSENSITIVITY; DERMATITIS; DIAGNOSTIC ERROR; DRUG ABSORPTION; DRUG BRAIN LEVEL; DRUG CLEARANCE; DRUG CONTRAINDICATION; DRUG DOSAGE FORM COMPARISON; DRUG ERUPTION; DRUG EXCRETION; DRUG HYPERSENSITIVITY; DRUG MECHANISM; DRUG PROTEIN BINDING; DRUG SAFETY; DRUG SENSITIVITY; DRUG SOLUBILITY; DRUG WITHDRAWAL; EDEMA; ENTEROBACTER; ENTEROCOCCUS; EOSINOPHILIA; ESCHERICHIA COLI; GLYCOGEN STORAGE DISEASE TYPE 1; HEMOLYSIS; HISTOPATHOLOGY; HUMAN; HYPERBILIRUBINEMIA; HYPEROSMOLALITY; IMMUNOLOGICAL PROCEDURES; KLEBSIELLA; LEG ULCER; LEUKOPENIA; LIVER DYSFUNCTION; LIVER TOXICITY; LONG TERM EXPOSURE; MAXIMUM ALLOWABLE CONCENTRATION; METHEMOGLOBINEMIA; NEPHROTIC SYNDROME; NEPHROTOXICITY; NONHUMAN; OCCUPATIONAL EXPOSURE; PATCH TEST; PROTEUS; PROVOCATION TEST; PSEUDOMONAS AERUGINOSA; SCALD; SIDE EFFECT; SILVER STAINING; SKIN DISCOLORATION; SKIN SCAR; SKIN TRANSPLANTATION; STAPHYLOCOCCUS AUREUS; STEROID THERAPY; STEVENS JOHNSON SYNDROME; THROMBOCYTOPENIA; TISSUE NECROSIS; TISSUE SECTION; TREATMENT DURATION; TREATMENT OUTCOME; URINARY TRACT INFECTION; WOUND CARE; WOUND DRESSING; WOUND HEALING; HYPERSENSITIVITY; OINTMENT; REVIEW; RISK FACTOR; SKIN ABSORPTION;

BURNS; DRUG RESISTANCE, BACTERIAL; HUMANS; HYPERSENSITIVITY; OINTMENTS; RISK FACTORS; SILVER SULFADIAZINE; SKIN ABSORPTION;

EID: 67849104592     PISSN: 1559047X     EISSN: 15590488     Source Type: Journal    
DOI: 10.1097/BCR.0b013e3181a28c9b     Document Type: Article

References (42)

1. Matuk Y, Ghosh M, McCulloch C. Distribution of silver in the eyes and plasma proteins of the albino rat. Can J Oph-thalmol 1981;16:145-150.
2. Bader KF. Organ deposition of silver following silver nitrate therapy of burns. Plastic Reconstr Surg 1966;37:550-551.
3. Ohura T. The Everett Idris Evans Memorial Lecture, 1987: twenty-five years experience treating burns. J Burn Care Re-habil 1988;9:106-117.
4. Coombs CJ, Wan AT, Masterton JP, Conyers RA, Pedersen J, Chia YT. Do burn patients have a silver lining? Burns 1992; 18:179-184.
5. Rosenman KD, Moss A, Kon S. Argyria: clinical implications of exposure to silver nitrate and silver oxide. J Occup Med 1979;21:430-435.
6. Boosalis MG, McCall JT, Ahrenholz DH, Solem LD, McClain CJ. Serum and urinary silver levels in thermal injury patients. Surgery 1987;101:40-43.
7. Wan AT, Conyers RA, Coombs CJ, Masterton JP. Determination of silver in blood, urine, and tissues of volunteers and burn patients. Clin Chem 1991;37:1683-1687.
8. Hirakawa K. Determination of silver and cerium in the liver and the kidney from a severely burned infant treated with silver sulfadiazine and cerium nitrate. Radioisotopes 1983; 32:59-65.
9. Trop M, Novak M, Rodl S, Hellbom B, Kroell W, Goessler W. Silver-coated dressing acticoat caused raised liver enzymes and argyria-like symptoms in burn patient. J Trauma 2006; 60:648-652.
10. Moss AP, Sugar A, Hargett NA, Atkin A, Wolkstein M, Rosenman KD. The ocular manifestations and functional effects of occupational argyrosis. Arch Opthalmol 1979;97: 906-908.
11. Rosenman KD, Seixas N, Jacobs I. Potential nephrotoxic effects of exposure to silver. Br J Ind Med 1987;44:267-272.
12. Iwasaki S, Yoshimura A, Ideura T, Koshikawa S, Sudo M. Elimination study of silver in a hemodialyzed burn patient treated with silver sulfadiazine cream. Am J Kidney Dis 1997; 30:287-290.
13. Eldad A, Icekson M, Zur T, et al. Silver-sulphadiazine eschar pigmentationa mimics invasive wound infection. J Burn Care Rehabil 2003;24:154-157.
14. Dupuis LL, Shear NH, Zuker RM. Hyperpigmentation due to topical application of silver sulfadiazine cream. J Am Acad Dermatol 1985;12:1112-1114.
15. Fisher NM, Marsh E, Lazova R. Scar-localized argyria secondary to silver sulfadizine cream. J Am Acad Dermatol 2003;49:730-732.
16. Fraser-Moodie A. Sensitivity to silver in a patient treated with silver sulphadiazine (Flamazine). Burns 1992;18:74-75.
17. Rowland Payne CM, Bladin C, Colchester AC, Bland J, Lapworth R, Lane D. Argyria from excessive use of topical silver sulphadiazine. Lancet 1992;340:126.
18. Owens CJ, Yarbrough DR III, Brackett NC Jr. Nephrotic syndrome following topically applied sulfadiazine silver therapy. Arch Int Med 1974;134:332-335.
19. Sawada Y. Adverse reaction to sulphonamides in a burned patient-a case report. Burns 1985;12:127-131.
20. McKenna SR, Latenser BA, Jones LM, Barrette RR, Sherman HF, Varcelotti JR. Serious silver sulphadiazine and mafenide acetate dermatitis. Burns 1995;21:310-312.
21. Lockhart SP, Rushworth A, Azmy AA, Raine PA. Topical silver sulphadiazine: side effects and urinary excretion. Burns 1984;10:109-112.
22. Eldad A, Neuman A, Weinberg A. Silver sulphadiazine-induced haemolytic anaemia in a glucose-6-phosphate dehydrogenase-deficient burn patient. Burns 1991;17: 430-432.
23. Kulick MI, Wong R, Okarma TB, Falces E, Berkowitz RL. Prospective study of side effects associated with the use of silver sulfadiazine in severely burned patients. Ann Plastic Surg 1985;14:407-419.
24. Tsai TC, Peng SK, Shih YR, Luk HN. Sulfadiazine-induced methemoglobinemia in a boy with thalassemia. Can J Anesth 2005;52:1002-1003.
25. Simon DI, Brosius FC, Rothstein DM. Sulfadiazine crystal-luria revisited. Arch Intern Med 1990;150:2379-2384.
26. Wolak E, Byerly FL, Mason T, Cairns BA. Methemoglobin-emia in critically ill burned patients. Am J Crit Care 2005;14: 104-108.
27. Fligner CL, Jack R, Twiggs GA, Raisys VA. Hyperosmolality induced by propylene glycol. A complication of silver sulfa-diazine therapy. JAMA 1985;253:1606-1609.
28. Kulick MI, Lewis NS, Bansal V, Warpeha R. Hyperosmolality in the burn patient: analysis of an osmolal discrepancy. J Trauma 1980;20: 223-228.
29. Porter WH, Auansakul A. Gas-chromatographic determination of ethylene glycol in serum. Clin Chem 1982;28: 75 -78.
30. Kelner MJ, Bailey DN. Propylene glycol as a cause of lactic acidosis. J Anal Toxicol 1985;9:40-42.
31. Goodman LS, Gilman A. Sulfonamides. In: The pharmacological basis of therapeutics. New York: The Macmillan Co; 1955. p. 1276-1320.
32. Miller SF. Blood platelets in severely injured burn patients [Letter]. Burns 1999;25:187.
33. Marvin JA, Heimbach DM, Engrav LH, Harnar TJ. Improved treatment of the Stevens-Johnson syndrome. Arch Surg 1984;119:601-605.
34. Leitch IOW, Kucukcelebi A, Robson MC. Inhibition of wound contraction by topical antibacterials. Aust NZJ Surg 1993;63:289-293.
35. Muller HJ, Hollyoak MA, Moaveni Z, Brown TL, Herndon DN, Heggers JP. Retardation of wound healing by silver sulfadiazine is reversed by Aloe vera and nystatin. Burns 2003; 29:834-836.
36. Gamelli RL, Paxton TP, O'Reilly M. Bone marrow toxicity by silver sulfadiazine. Surg Gynecol Obstet 1993;177:115-120.
37. Gamelli RL, Herbert JC, Foster RS Jr. Effect of burn injury on granulocyte and macrophage production. J Trauma 1985; 25:615-619.
38. Cartotto R, Gomez M, Leow M, et al. Silver sulfadiazine (SSD) does not cause early post burn leukopenia (EPBL): a prospective study. In: Proceedings of the 37th Annual Meeting of the American Burn Association, Chicago, Illinois; 2005,26:S89.
39. Thomson PD, Moore NP, Rice TL, Prasad JK. Leukopenia in acute thermal injury: evidence against topical silver sulfadia-zine as the causative agent. J Burn Care Rehabil 1989;10: 418-420.
40. Anonymous. Silver sulfadiazine cream drug package insert. Marion Laboratories; 1974.
41. Neely AN, Gardner J, Durkee P, et al. Are topical antibacte-rials effective against bacteria that are highly resistant to systemic antibiotics? In: Proceedings of the 40th annual meeting of the American Burn Association, Chicago, Illinois; 2008,29:S104.
42. Heggers JP, Robson MC. The emergence of silver sulphadiazine-resistant Pseudomonas aeruginosa. Burns 1979;5:184-187.